MultiStem
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Rationale MultiStem® (HLM051) is one of the promising allogenic cell products for acute ischemic stroke with strong evidence. A…
I schemic stroke is caused by a blockage of blood flow to the brain. A leading cause of death and disability globally, each year…
Introduction:
MultiStem is an adult, adherent, stem cell product, having shown safety and efficacy in other clinical…
MultiStem cells are clinical‐grade multipotent adult bone marrow‐derived progenitor cells (MAPCs), with extensive replication…
Background There is growing interest in neurorestorative and reparative therapies after acute stroke. MultiStem® is an allogeneic…
The last decade has seen much progress in adjunctive cell therapy for immune disorders. Both corporate and institutional Phase…
Rationale: MultiStem is an allogeneic bone marrow–derived adherent adult stem cell product that has shown efficacy in preclinical…
The therapeutic benefits of adult adherent stem cells are currently being investigated in clinical trials for a variety of…
The ecology and evolutionary potential of coast redwood (Sequoia sempervirens) is significantly influenced by the important role…